Sedation Effect on the Global Quality Colonoscopy

NCT02220530 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 7000

Last updated 2014-08-20

No results posted yet for this study

Summary

This study aims to assess the impact of the use of sedation on the overall quality of the colonoscopy, therefore addressing each and every one of its dimensions, namely: scientific and technical quality, perceived quality and safety.

Conditions

  • Ambulatory Patients Referred for a First-time Colonoscopy

Interventions

DRUG

Conscious sedation with iv midazolam and fentanyl.

Sedation group: Conscious sedation with iv midazolam and fentanyl dosed according to age, weight and baseline conditions of the patients.

Sponsors & Collaborators

  • Hospital San Juan de Dios Tenerife

    lead OTHER

Principal Investigators

  • Juan Salvador Baudet, M. D. · Hospital San Juan de Dios Tenerife

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-10-31
Primary Completion
2015-10-31
Completion
2015-11-30

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02220530 on ClinicalTrials.gov